Home
De nobis
De Gentolex
Factory Tour
Culture
FAQs
Products
Chemicals
Intermedia chemica
Chemicals Organic
Inorganics Chemicals
catalysts et Auxiliares
Pharma Ingredients
Pharma APIs
Anti-infectivum
Ratio cardiovascularis
Alia Apis
Systema generationis
Secretio System
Pharma Intermedia
Amino acida
Cosmetics Peptide
Service
Procurement Service
CRO&CDMO
News CELLA
Nobis loquere
English
Home
News
Industria nuntium
Acadia Trofinetide Phase III Fusce Top-Line Proventus Positivus
by on 22-02-17
Die 2021-12-06, tempore US, Acadia pharmaceutica (Nasdaq: ACAD) nuntiavit eventus positivus top-lineus sui phase III clinici iudicii sui medicamentorum candidatorum Trofinetide.Pascha III iudicium, nomine Lavender, maxime aestimare solebat salus et efficacia Trofinetide in tractatione Rei...
Lege plus
Progressus investigationis peptidum opioideorum ex approbatione Difelikefalin
by on 22-02-17
Cum diluculo ad 2021-08-24, Cara Therapeutica et socium suum negotium Vifor Pharma denuntiavit se receptaculum opioidum primogenitum in classe agonista difelikefalin (KORSUVA™) a FDA probatum esse ad curationem morbi longi renis (CKD) aegrorum. (Moderator positivum / gravibus pruritus cum hemod ...
Lege plus
RhoVac Cancer peptide Vaccine RV001 patentes a Canadian Intellectual Property Office
by on 22-02-17
Canada tempus 2022-01-24, RhoVac, societas pharmaceutica ad immunologiam tumorem tendit, nuntiavit applicationem eius patentem (No. 2710061) propter cancrum peptidum vaccinum RV001 auctoritate Intellectualis Canadiensis Officii (CIPO).Antea, societas diplomata relat.
Lege plus
Intrare quaerere vel ESC claudere